Investment ThemesDetailed Quotes
CAR-T Therapy
Watchlist
- 997.037
- +0.761+0.08%
Trading Jan 24 12:15 ET
998.174High992.325Low
993.599Open996.276Pre Close20.53MVolume8Rise21.67P/E (Static)1.31BTurnover--Flatline0.15%Turnover Ratio1.05TMarket Cap2Fall1.04TFloat Cap
Constituent Stocks: 10Top Rising: ADAP+3.47%
Sign in to post a comment
$Pfizer (PFE.US)$ Whats with the up and downs 😂😂
3
Little update on the wheel strategy, recently placed a new CSP into $Johnson & Johnson (JNJ.US)$ cause the price was irresistible after their earnings.
Buy the Close yesterday and net premium off: USD 125.00 (approxi. USD 2.00 Fees)
Current Wheel Positions
Buy the Close yesterday and net premium off: USD 125.00 (approxi. USD 2.00 Fees)
Current Wheel Positions
loading...
4
Something wrong with the overnight price?😂
1
News Highlights
1. $Pfizer (PFE.US)$'s shares rose 1.6% on Thursday, with the most traded calls are contracts of $25 strike price that expire on Jan 24 and the total volume reaching 77,418 with the open interest of 10,228.
Pfizer was the target of unusually large options trading on Thursday. Stock investors purchased 251,131 call options on the company. This represents an increase of 54% co...
1. $Pfizer (PFE.US)$'s shares rose 1.6% on Thursday, with the most traded calls are contracts of $25 strike price that expire on Jan 24 and the total volume reaching 77,418 with the open interest of 10,228.
Pfizer was the target of unusually large options trading on Thursday. Stock investors purchased 251,131 call options on the company. This represents an increase of 54% co...
+1
14
11
$Johnson & Johnson (JNJ.US)$ ok yep I'm a idiot for selling ill admit it lol 😆
1
1
$Pfizer (PFE.US)$ lets go for high dividen and keep for long term!
2
3
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
$Pfizer (PFE.US)$ trump is gonna reveal pfizer scam soon, should i sell ?
1
5
$Pfizer (PFE.US)$
Tomorrow is the XD.
Tomorrow is the XD.
2
3
$Esperion Therapeutics (ESPR.US)$ Jan 23, 2025 Three analysts are bullish on Esperion Therapeutics with price targets on this $2 stock ranging from $7 to $16 a share.
Multiple sources indicate that Esperion's advancements and commercial success with its cholesterol-lowering drugs, NEXLIZET and NEXLETOL, Esperion has positioned itself as an acquisition target for larger pharmaceutical compa...
Multiple sources indicate that Esperion's advancements and commercial success with its cholesterol-lowering drugs, NEXLIZET and NEXLETOL, Esperion has positioned itself as an acquisition target for larger pharmaceutical compa...
5
3
2
No comment yet
Deep Sea : playing char char dance![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
RenenoMirai OP Deep Sea : Yeah, completely not disturbed, collect my dividend and sit back relax
102918195 : won't go up much...buy Abbott faster